Details for New Drug Application (NDA): 218303
✉ Email this page to a colleague
The generic ingredient in BISOPROLOL FUMARATE is bisoprolol fumarate; hydrochlorothiazide. There are twelve drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the bisoprolol fumarate; hydrochlorothiazide profile page.
Summary for 218303
| Tradename: | BISOPROLOL FUMARATE |
| Applicant: | Micro Labs |
| Ingredient: | bisoprolol fumarate |
| Patents: | 0 |
Pharmacology for NDA: 218303
| Mechanism of Action | Adrenergic beta-Antagonists |
Medical Subject Heading (MeSH) Categories for 218303
Suppliers and Packaging for NDA: 218303
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| BISOPROLOL FUMARATE | bisoprolol fumarate | TABLET;ORAL | 218303 | ANDA | Micro Labs Limited | 42571-470 | 42571-470-01 | 100 TABLET, FILM COATED in 1 BOTTLE (42571-470-01) |
| BISOPROLOL FUMARATE | bisoprolol fumarate | TABLET;ORAL | 218303 | ANDA | Micro Labs Limited | 42571-470 | 42571-470-05 | 500 TABLET, FILM COATED in 1 BOTTLE (42571-470-05) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
| Approval Date: | Mar 9, 2026 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
| Approval Date: | Mar 9, 2026 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
